文献速递血栓与止血

血小板计数及指数作为产后出血危险因素:回顾性队列研究

Platelet count and indices as postpartum hemorrhage risk factors: a retrospective cohort study.
PubMed 文献 · J Thromb Haemost · 2021-08-20

BACKGROUND: Severe postpartum hemorrhage (SPPH) is the leading cause of maternal mortality and morbidity worldwide. Platelet anomalies frequently occur during pregnancy. However, their role in the etiology of SPPH is largely unknown.…

要点

  • 血小板减少(<150×10^9/L)者SPPH风险升高(aOR 1.34,95%CI 1.14-1.59)。
  • 血小板<50×10^9/L者SPPH风险最高(aOR 2.24,95%CI 1.01-4.94)。
  • 血小板压积和PDW≥23%与SPPH相关,但附加价值有限。

核心结论

  • 不同程度血小板减少与SPPH发生独立相关。
  • 血小板压积和PDW≥23%虽与SPPH相关,但在血小板计数之外附加价值有限。

研究设计与样本

  • 回顾性单中心队列研究,纳入2009至2017年间分娩。
  • 血小板参数于分娩前72小时内测量,缺失数据采用多重插补。

主要发现

  • 2402例(10.4%)存在血小板减少(<150×10^9/L),其中10.3%发生SPPH,而血小板计数正常者SPPH发生率为7.6%。
  • 血小板减少者SPPH的aOR为1.34(95%CI 1.14-1.59),校正因素包括母亲年龄、多胎妊娠、巨大儿、引产、子痫前期和HELLP综合征。
  • 血小板<50×10^9/L者aOR为2.24(95%CI 1.01-4.94);50-99×10^9/L者aOR为1.22(95%CI 0.77-1.93);100-149×10^9/L者aOR为1.31(95%CI 1.10-1.56)。
  • 血小板压积每降低0.05%,SPPH的aOR为1.15(95%CI 1.08-1.21)。
  • PDW≥23%(n=22)者SPPH的aOR为6.05(95%CI 2.29-16.20)。

临床怎么用

  • 产前应关注血小板计数,尤其血小板<150×10^9/L者需警惕SPPH风险。
  • 血小板<50×10^9/L者SPPH风险显著升高,应加强监测与准备。
  • 血小板压积和PDW可作为辅助指标,但不应替代血小板计数用于风险评估。

局限性

  • 回顾性单中心设计可能限制外推性。
  • PDW≥23%者样本量小(n=22),结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe postpartum hemorrhage (SPPH) is the leading cause of maternal mortality and morbidity worldwide. Platelet anomalies frequently occur during pregnancy. However, their role in the etiology of SPPH is largely unknown. OBJECTIVE: To study the relation between platelet parameters and SPPH. METHODS: This retrospective single-center cohort included deliveries between 2009 and 2017. SPPH was defined as ≥1000 ml blood loss within 24 h after delivery. Platelet parameters were measured within 72 h before delivery. Multiple imputation was performed for missing data. Odds ratios were adjusted (aORs) for maternal age, multiple gestation, macrosomia, induction of labor, preeclampsia, and hemolysis, elevated liver enzymes, and low platelets syndrome. RESULTS: A total of 23 205 deliveries were included. Of the 2402 (10.4%) women with thrombocytopenia (<150 × 109 /L), 10.3% developed SPPH, compared with 7.6% of women with a normal platelet count (aOR: 1.34, 95% CI: 1.14-1.59). Women with a platelet count of <50 × 109 /L were most at risk (aOR of 2.24 [1.01-4.94]) compared with the reference group with normal platelet counts; the aOR was 1.22 (0.77-1.93) for the 50-99 × 109 /L platelet count group and 1.31 (1.10-1.56) for the 100-149 × 109 /L platelet count group. Plateletcrit was associated with SPPH (aOR 1.15 [1.08-1.21] per 0.05% decrease), and, although rarely present, a platelet distribution width (PDW) ≥23% (n = 22) also increased the odds of SPPH (aOR 6.05 [2.29-16.20]). CONCLUSION: Different degrees of thrombocytopenia were independently associated with the occurrence of SPPH. Despite their relation to SPPH, plateletcrit and a PDW of ≥23% have limited additional value in addition to platelet count.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. van Dijk WEM, Nijdam JS, Haitjema S, et al. Platelet count and indices as postpartum hemorrhage risk factors: a retrospective cohort study. J Thromb Haemost. 2021. PMID: 34339085. doi:10.1111/jth.15481

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。